322 related articles for article (PubMed ID: 28418876)
1. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level.
Zhu L; Huang Q; Xie Z; Kang M; Ding H; Chen B; Chen Y; Liu C; Wang Y; Tang W
Oncotarget; 2017 Jun; 8(23):37308-37320. PubMed ID: 28418876
[TBL] [Abstract][Full Text] [Related]
2. Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population.
Chen B; Wang Y; Tang W; Chen Y; Liu C; Kang M; Xie J
BMC Med Genomics; 2022 Dec; 15(1):274. PubMed ID: 36587194
[TBL] [Abstract][Full Text] [Related]
3.
Lin J; Chen Y; Tang WF; Liu C; Zhang S; Guo ZQ; Chen G; Zheng XW
Front Oncol; 2019; 9():63. PubMed ID: 30838172
[No Abstract] [Full Text] [Related]
4. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
[TBL] [Abstract][Full Text] [Related]
5. Assessment of
Chen Z; Wang Y; Wang J; Kang M; Tang W; Chen S
DNA Cell Biol; 2020 Sep; 39(9):1521-1531. PubMed ID: 32721231
[TBL] [Abstract][Full Text] [Related]
6. Relationship of
Zhang S; Jiang J; Chen Z; Wang Y; Tang W; Chen Y; Liu L
Onco Targets Ther; 2018; 11():4651-4660. PubMed ID: 30122956
[TBL] [Abstract][Full Text] [Related]
7. Association of PGC-1α gene with type 2 diabetes in three unrelated endogamous groups of North-West India (Punjab): a case-control and meta-analysis study.
Sharma R; Matharoo K; Kapoor R; Bhanwer AJS
Mol Genet Genomics; 2018 Apr; 293(2):317-329. PubMed ID: 29063962
[TBL] [Abstract][Full Text] [Related]
8. Haplotype-based interaction of the PPARGC1A and UCP1 genes is associated with impaired fasting glucose or type 2 diabetes mellitus.
Pei X; Liu L; Cai J; Wei W; Shen Y; Wang Y; Chen Y; Sun P; Imam MU; Ping Z; Fu X
Medicine (Baltimore); 2017 Jun; 96(23):e6941. PubMed ID: 28591028
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis.
Chang WC; Jan Wu YJ; Chung WH; Lee YS; Chin SW; Chen TJ; Chang YS; Chen DY; Hung SI
Rheumatology (Oxford); 2017 Mar; 56(3):457-466. PubMed ID: 28394398
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
11. Genetic susceptibility to pre diabetes mellitus and related association with obesity and physical fitness components in Mexican-Mestizos.
Costa-Urrutia P; Abud C; Franco-Trecu V; Colistro V; Rodríguez-Arellano ME; Granados J; Seelaender M
Prim Care Diabetes; 2018 Oct; 12(5):416-424. PubMed ID: 30041843
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of the peroxisome proliferator-activated receptor-γ (rs1801282) and its coactivator-1 (rs8192673) are associated with obesity indexes in subjects with type 2 diabetes mellitus.
Kruzliak P; Haley AP; Starcevic JN; Gaspar L; Petrovic D
Cardiovasc Diabetol; 2015 Apr; 14():42. PubMed ID: 25928419
[TBL] [Abstract][Full Text] [Related]
13. Effects of
Muntean C; Sasaran MO; Crisan A; Banescu C
Front Public Health; 2022; 10():962852. PubMed ID: 36466447
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population.
Zhu S; Liu Y; Wang X; Wu X; Zhu X; Li J; Ma J; Gu HF; Liu Y
Diabetes Res Clin Pract; 2009 Dec; 86(3):168-72. PubMed ID: 19828207
[TBL] [Abstract][Full Text] [Related]
15. Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled trial.
Kopp TI; Jensen DM; Ravn-Haren G; Cohen A; Sommer HM; Dragsted LO; Tjonneland A; Hougaard DM; Vogel U
BMC Cancer; 2016 Apr; 16():283. PubMed ID: 27102200
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in the peroxisome proliferator-activated receptor (PPAR) and peroxisome proliferator-activated receptor gamma co-activator 1 (PGC1) gene families and type 2 diabetes.
Villegas R; Williams SM; Gao YT; Long J; Shi J; Cai H; Li H; Chen CC; Tai ES; ; Hu F; Cai Q; Zheng W; Shu XO
Ann Hum Genet; 2014 Jan; 78(1):23-32. PubMed ID: 24359475
[TBL] [Abstract][Full Text] [Related]
17. Putative association of peroxisome proliferator-activated receptor gamma co-activator 1beta (PPARGC1B) polymorphism with Type 2 diabetes mellitus.
Park KS; Shin HD; Park BL; Cheong HS; Cho YM; Lee HK; Lee JY; Lee JK; Kim HT; Park CS; Han BG; Kimm K; Oh B
Diabet Med; 2006 Jun; 23(6):635-42. PubMed ID: 16759305
[TBL] [Abstract][Full Text] [Related]
18. The Role of Peroxisome Proliferator-Activated Receptors and Their Transcriptional Coactivators Gene Variations in Human Trainability: A Systematic Review.
Petr M; Stastny P; Zajac A; Tufano JJ; Maciejewska-Skrendo A
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29762540
[TBL] [Abstract][Full Text] [Related]
19. Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer.
Wirtenberger M; Tchatchou S; Hemminki K; Schmutzhard J; Sutter C; Schmutzler RK; Meindl A; Wappenschmidt B; Kiechle M; Arnold N; Weber BH; Niederacher D; Bartram CR; Burwinkel B
Carcinogenesis; 2006 Nov; 27(11):2201-8. PubMed ID: 16704985
[TBL] [Abstract][Full Text] [Related]
20. Association between
Wang YZ; Zhang HY; Liu F; Li L; Deng SM; He ZY
Neural Regen Res; 2019 Nov; 14(11):1986-1993. PubMed ID: 31290457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
